Cytomegalovirus infection and disease after autologous peripheral blood stem cell transplantation

British Journal of Haematology

Volumn 115, Issue 4, 2001, Pages 1032-1033

  Peggs, K S ^a   Mackinnon, S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antigenaemia; Autologous; Cytomegalovirus; Polymerase chain reaction; Stem cell transplantation

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR;

AUTOTRANSPLANTATION; BONE MARROW SUPPRESSION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; HUMAN; LETTER; PRIORITY JOURNAL; SCREENING TEST; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS LOAD; VIRUS REACTIVATION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION, AUTOLOGOUS; UNNECESSARY PROCEDURES; VIRAL LOAD;

EID: 0035673078     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.03152.x     Document Type: Letter

References (6)

1. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study
2. Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation
3. Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: High rates of reactivation in patients with multiple myeloma and lymphoma
4. Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation
5. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
6. Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: No evidence of increased incidence based on polymerase-chain-reaction monitoring